Cohen; Margo P.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Cohen; Margo P..The latest application filed is for "methods and compositions for treatment of disorders associated with damage induced by free radicals".

Company Profile

0.7.7

Cohen; Margo P. - New York NY
Cohen; Margo P. - NY NY

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Methods And Compositions For Treatment Of Disorders Associated With Damage Induced By Free Radicals App 20170157010 - Cohen; Margo P. ; et al.	2017-06-08
Long-acting and controlled release formulations of 2-[(3-chlorophenyl) amino] phenylacetic acid Grant 8,962,020 - Cohen , et al. February 24, 2	2015-02-24
Long-acting And Controlled Release Formulations Of 2-[(3-chlorophenyl) Amino] Phenylacetic Acid App 20140030325 - Cohen; Margo P. ; et al.	2014-01-30
Methods And Compositions Comprising 2-[(3-chlorophenyl) Amino] Phenylacetic Acid For Hyperpermeability And Neovascularization Disorders Of The Retina App 20100035993 - Cohen; Margo P. ; et al.	2010-02-11
Methods and Composition Comprising 2-[(3-Chlorophenyl)Amino] Phenylacetic Acid for Alzheimer's Disease App 20080255236 - Cohen; Margo P. ; et al.	2008-10-16
Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies Grant 6,552,077 - Cohen April 22, 2	2003-04-22
Albumin-binding compounds that prevent nonenzymatic glycation and that may be used for treatment of glycation-related pathologies App 20010034359 - Cohen, Margo P.	2001-10-25
In vivo methods of treatment to prevent kidney dysfunction using substances that inhibit albumin glycation Grant 6,001,875 - Cohen , et al. December 14, 1	1999-12-14
In Vivo Methods to reduce hypercholesterolemia and improve vascular dysfunction Grant 5,994,401 - Cohen , et al. November 30, 1	1999-11-30
Genetically engineered immunoglobulins with specificity for glycated albumin Grant 5,908,925 - Cohen , et al. June 1, 1	1999-06-01
Monoclonal antibodies against glycated albumin, hybrid cell lines producing these antibodies, and use therefore Grant 5,223,392 - Cohen June 29, 1	1993-06-29

Company Registrations

NCAGE Code	48NY2	COHEN MARGO P
CAGE Code	48NY2	COHEN MARGO P

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.